EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Nanoformulations in epilepsy therapy – a systematic review of emerging strategies in status epilepticus

Nuraziemah Ahmad, Mohmad Farooq Shaikh, Mohammed Tahir Ansari, Alina Arulsamy

DARU Journal of Pharmaceutical Sciences · 18.09.2025 · 33 (2)

DOI: 10.1007/s40199-025-00575-w ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift DARU Journal of Pharmaceutical Sciences, online erschienen am 18.09.2025. Verfasst von Nuraziemah Ahmad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Neuropharmacology Research Laboratory, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia. Hauptthemen laut MEDLINE: Status Epilepticus, Anticonvulsants, Nanoparticles, Nanoparticle Drug Delivery System. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Monash University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Status epilepticus (SE) presents a life-threatening medical emergency condition characterized by prolonged seizures, leading to severe neuronal damage, morbidity and mortality, if not promptly treated. Immediate intervention is crucial, yet current anti-seizure medications (ASM) face limitations such as adverse effects otherwise in need of invasive administration routes such as intravenous ASMs. Nanoparticle-based drug delivery systems offer a promising approach to overcoming these challenges by enhancing drug solubility, stability, and brain bioavailability. This systematic review examines recent advancements in nanoformulations of ASMs for SE management. Through a comprehensive search and analysis of the literature, 12 relevant studies were identified, highlighting various nanoparticle types, formulation methods, and pharmacokinetic parameters. ASM nanoparticles exhibit favourable characteristics for drug delivery, including small size, high surface area, and tuneable physicochemical properties. These properties enable efficient drug transport across biological barriers, precise targeting, and controlled release, ultimately improving drug efficacy and reducing side effects. With an optimized release profile and non-invasive route such as intranasal administration, nano-formulated ASMs offer promising immediate therapeutic strategy for SE therapy. However, further research is warranted to optimize nano-formulation parameters, assess long-term safety, and validate clinical efficacy. Overall, nanoparticle-based ASM delivery holds great potential for revolutionizing SE treatment, offering hope for improved patient outcomes and quality of life. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Status EpilepticusAnticonvulsantsNanoparticlesNanoparticle Drug Delivery SystemHumansAnimalsDrug Delivery Systems

Stichwörter der Autor:innen

Anti-Seizure medicationsEpilepsyNanoformulationsStatus epilepticus

Substanzen

AnticonvulsantsNanoparticle Drug Delivery System

Autor:innen und Institutionen

  • Neuropharmacology Research Laboratory, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia.
  • School of Dentistry and Medical Sciences, Charles Sturt University, Orange, NSW, Australia.
  • School of Pharmacy, University of Nottingham Malaysia, Semenyih, Selangor, Malaysia.
  • Neuropharmacology Research Laboratory, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia. alina.arulsamy@monash.edu.

Förderung

  • Monash University

Zitieren

APA

Ahmad, N., Shaikh, M. F., Ansari, M. T., & Arulsamy, A. (2025). Nanoformulations in epilepsy therapy – a systematic review of emerging strategies in status epilepticus. DARU Journal of Pharmaceutical Sciences, 33(2). https://doi.org/10.1007/s40199-025-00575-w

Vancouver

Ahmad N, Shaikh MF, Ansari MT, Arulsamy A. Nanoformulations in epilepsy therapy – a systematic review of emerging strategies in status epilepticus. DARU Journal of Pharmaceutical Sciences. 2025;33(2). doi:10.1007/s40199-025-00575-w

BibTeX
@article{Ahmad2025,
  author = {Ahmad, Nuraziemah and Shaikh, Mohmad Farooq and Ansari, Mohammed Tahir and Arulsamy, Alina},
  title = {Nanoformulations in epilepsy therapy – a systematic review of emerging strategies in status epilepticus},
  journal = {DARU Journal of Pharmaceutical Sciences},
  year = {2025},
  volume = {33},
  number = {2},
  doi = {10.1007/s40199-025-00575-w}
}
Kostenlos starten →